This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Other. Active years: 1998-2002.
Location History:
- Sainte Foy Les Lyon, FR (1998)
- Paris, FR (1999 - 2002)
Company Filing History:
2 out of 1,853 
1 out of 834,411 Years Active: 1998-2002
Title: The Innovative Contributions of Christophe Torrent
Introduction
Christophe Torrent is a notable inventor based in Paris, France. He has made significant contributions to the field of viral particle production, holding a total of 3 patents. His work focuses on methods and compositions that enhance the transfer of nucleic acids into cells, which has important implications for medical research and therapies.
Latest Patents
One of his latest patents is titled "Methods and compositions for producing viral particles." This invention concerns methods and constructs for producing retroviral particles, whether in vitro, ex vivo, or in vivo. It also addresses the use of these methods and constructs for transferring nucleic acids into cells. More specifically, the invention includes a composition that comprises the entire set of genetic elements required for constituting a retroviral particle, which is incorporated in one or several recombinant adenoviruses that are defective for all or part of the regions E1 and E4 at least, known as adenoviral/retroviral chimeric vectors. Another significant patent is related to the "Internal ribosome entry site, vector containing it and therapeutic use," which further showcases his innovative approach to viral research.
Career Highlights
Throughout his career, Christophe Torrent has worked with esteemed institutions, including the National Institute of Health and Medical Research. His research has contributed to advancements in the understanding and application of viral vectors in gene therapy.
Collaborations
He has collaborated with notable colleagues such as Jean-Luc Darlix and Clarisse Berlioz, which has enriched his research and expanded the impact of his inventions.
Conclusion
Christophe Torrent's innovative work in the field of viral particle production and gene therapy exemplifies the importance of research and collaboration in advancing medical science. His contributions continue to influence the landscape of biotechnology and therapeutic development.